(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.

Chevron to Invest $7 Billion to Double Its Venezuelan Output
23:39

Apple’s Ternus Takes Reins as CEO With AI a Priority
26:54

Nvidia to Invest $3.5 Billion in Chipmaker MediaTek
22:06